Literature DB >> 14708636

CD34 microvessel density and VEGF expression in basal and squamous cell carcinoma.

Barbara Loggini1, Laura Boldrini, Silvia Gisfredi, Silvia Ursino, Tiziano Camacci, Katia De Jeso, Gregorio Cervadoro, Raffaele Pingitore, Paolo Barachini, Pietro Leocata, Gabriella Fontanini.   

Abstract

Angiogenesis is a central process in the growth of solid tumors. The purpose of our study was to analyze the angiogenic pattern in squamous and basal cell carcinomas and to point out differences in microvessel density that could explain their different biological behaviour. Thirty-nine skin tumors (26 basal and 13 squamous cell carcinomas) were analyzed. In all samples, the microvessels density (MVD) and the levels of vascular endothelial growth factor mRNA (VEGFmRNA) were analyzed, together with the inter-relationship between these two variables. Using the median value of the entire series (33 vessels per 2.22 mm2), tumors with low and high MVD were identified. The majority of cancers with high vascularization belonged to the squamous histotype (12 of 39), while 19 of the 26 basal cell carcinomas showed a lower number of microvessels than the median value (p = 0.0001). The median value of VEGFcDNA quantitation allowed us to distinguish tumors with high VEGF expression (> 470 molecules cDNA) from those with low (< or = 470 molecules) VEGF expression: 20 of the 26 basal cell carcinomas showed low VEGF expression, while 11 of the 13 squamous cell carcinomas showed high VEGFcDNA levels (p = 0.0003). Moreover, a significant association between a high microvessel density and high VEGFmRNA levels (p = 0.006) was found. Furthermore, when studying VEGF expression by immunohistochemistry, we obtained similar results and noted a correlation with VEGFmRNA expression (p < 0.0001). The association between high vascularization, high VEGF levels, and squamous cell histotype suggests the possible role of neoangiogenesis in determining the more aggressive biological behaviour of this type of cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14708636     DOI: 10.1078/0344-0338-00486

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  6 in total

1.  Computational modelling of anti-angiogenic therapies based on multiparametric molecular imaging data.

Authors:  Benjamin Titz; Kevin R Kozak; Robert Jeraj
Journal:  Phys Med Biol       Date:  2012-09-13       Impact factor: 3.609

2.  Efficiency of long-term high-dose intravenous ascorbic acid therapy in locally advanced basal cell carcinoma - a pilot study.

Authors:  András Bánvölgyi; Kende Lőrincz; Norbert Kiss; Pinar Avci; Luca Fésűs; Róbert Szipőcs; Tibor Krenács; Nóra Gyöngyösi; Norbert Wikonkál; Sarolta Kárpáti; Krisztián Németh
Journal:  Postepy Dermatol Alergol       Date:  2019-02-26       Impact factor: 1.837

3.  Blood vessel density in Basal cell carcinomas and benign trichogenic tumors as a marker for differential diagnosis in dermatopathology.

Authors:  Julia Winter; Hermann Kneitz; Eva-B Bröcker
Journal:  J Skin Cancer       Date:  2010-10-07

4.  Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.

Authors:  Rosalyn D Blumenthal; Evelyn Leon; Hans J Hansen; David M Goldenberg
Journal:  BMC Cancer       Date:  2007-01-03       Impact factor: 4.430

5.  Assessment of Density of Neovascularization in Lower Lip Squamous Cell Carcinoma in Relation To Neoplasm Differentiation Grade in Patients with and without Neck Lymph Nodes Metastasis.

Authors:  Lena Kakasheva-Mazhenkovska; Marko Kostovski; Gjorgje Gjokik; Vesna Janevska
Journal:  Open Access Maced J Med Sci       Date:  2019-01-03

6.  Squamous cell carcinomas of the skin explore angiogenesis-independent mechanisms of tumour vascularization.

Authors:  Ievgenia Pastushenko; Tamara Gracia-Cazaña; Sandra Vicente-Arregui; Gert G Van den Eynden; Mariano Ara; Peter B Vermeulen; Franciso José Carapeto; Steven J Van Laere
Journal:  J Skin Cancer       Date:  2014-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.